PPBT Purple Biotech

USD 2.67 -0.21 ( -7.21%)
Icon

Purple Biotech (PPBT) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.67

-0.21 (-7.21%)

USD 6.62M

8.97K

USD -1.00

USD 3.63 (+35.83%)

Icon

PPBT

Purple Biotech (USD)
COMMON STOCK | NSD
USD 2.67
-0.21 ( -7.21%)

Purple Biotech (PPBT) Annual Income Statement (USD)

PPBT Quarterly Financials (USD)

Frequently Asked Questions About Purple Biotech (PPBT) Stock

Purple Biotech's (PPBT) last reported annual revenue was USD 0.00.

Purple Biotech's (PPBT) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A

Purple Biotech's(PPBT) is not profitable as of its last reported annual financials.

The net profit margin for Purple Biotech's(PPBT) from its laster reported year is N/A

The return on equity (ROE) for Purple Biotech's(PPBT) from its last reported annual financials is : -21.66%

The return on assets (ROA) for Purple Biotech's(PPBT) from its last reported annual financials is : -16.60%

The return on invested capital (ROIC) for Purple Biotech's(PPBT) from its last reported annual financials is : -32.82%

The Debt to Equity ratio for Purple Biotech's(PPBT) from its last reported annual financials is : 0.00%

The dividend yield for Purple Biotech's(PPBT) from its laster reported year is 0.00%

Purple Biotech's(PPBT) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...